EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Defined Bacterial Consortium Efficacy in the Biodegradation of NSAIDs

Ariel Marchlewicz iD, Urszula Guzik iD, Katarzyna Hupert-Kocurek iD, Danuta Wojcieszyńska iD

Molecules · 2023

DOI: 10.3390/molecules28052185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Ariel Marchlewicz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biology, Biotechnology and Environmental Protection, Faculty of Natural Science, University of Silesia in Katowice, Jagiellońska 28, 40-…. Hauptthemen laut MEDLINE: Ibuprofen, Naproxen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Centre for Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to the increasing pollution of wastewater with non-steroidal anti-inflammatory drugs, preparations need to be developed to decompose these drugs. This work aimed to develop a bacterial consortium with a defined composition and boundary conditions for the degradation of paracetamol and selected non-steroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, naproxen, and diclofenac. The defined bacterial consortium consisted of Bacillus thuringiensis B1(2015b) and Pseudomonas moorei KB4 strains in a ratio of 1:2. During the tests, it was shown that the bacterial consortium worked in the pH range from 5.5 to 9 and temperatures of 15–35 °C, and its great advantage was its resistance to toxic compounds present in sewage, such as organic solvents, phenols, and metal ions. The degradation tests showed that, in the presence of the defined bacterial consortium in the sequencing batch reactor (SBR), drug degradation occurred at rates of 4.88, 10, 0.1, and 0.05 mg/day for ibuprofen, paracetamol, naproxen, and diclofenac, respectively. In addition, the presence of the tested strains was demonstrated during the experiment as well as after its completion. Therefore, the advantage of the described bacterial consortium is its resistance to the antagonistic effects of the activated sludge microbiome, which will enable it to be tested in real activated sludge conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IbuprofenNaproxenDiclofenacAcetaminophenSewageAnti-Inflammatory Agents, Non-Steroidal

Stichwörter der Autor:innen

BacillusNSAIDsPseudomonasdefined bacterial consortiumdegradation

Substanzen

IbuprofenNaproxenDiclofenacAcetaminophenSewageAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Institute of Biology, Biotechnology and Environmental Protection, Faculty of Natural Science, University of Silesia in Katowice, Jagiellońska 28, 40-032 Katowice, Poland.

ORCID-Profile: Ariel Marchlewicz, Urszula Guzik, Katarzyna Hupert-Kocurek, Danuta Wojcieszyńska

Förderung

  • National Centre for Research and Development

Zitieren

APA

Marchlewicz, A., Guzik, U., Hupert-Kocurek, K., & Wojcieszyńska, D. (2023). Evaluation of the Defined Bacterial Consortium Efficacy in the Biodegradation of NSAIDs. Molecules. https://doi.org/10.3390/molecules28052185

Vancouver

Marchlewicz A, Guzik U, Hupert-Kocurek K, Wojcieszyńska D. Evaluation of the Defined Bacterial Consortium Efficacy in the Biodegradation of NSAIDs. Molecules. 2023. doi:10.3390/molecules28052185

BibTeX
@article{Marchlewicz2023,
  author = {Marchlewicz, Ariel and Guzik, Urszula and Hupert-Kocurek, Katarzyna and Wojcieszyńska, Danuta},
  title = {Evaluation of the Defined Bacterial Consortium Efficacy in the Biodegradation of NSAIDs},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28052185}
}
Kostenlos starten →